| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.97 | 0.001 | 0.97 | Androgen antagonist | 0.407 0.005 CID_131770037 | ||
| 0.886 | 0.002 | 0.886 | Diuretic | 0.881 0.002 CID_131770037 | ||
| 0.858 | 0.001 | 0.858 | Mineralocorticoid receptor antagonist | 0.837 0.001 CID_131770037 | ||
| 0.856 | 0.001 | 0.856 | Androgen agonist | 0.222 0.004 CID_131770037 | ||
| 0.862 | 0.009 | 0.862 | Apoptosis agonist | 0.593 0.05 CID_131770037 | ||
| 0.735 | 0.001 | 0.735 | Aldosterone antagonist | 0.539 0.001 CID_131770037 | ||
| 0.743 | 0.023 | 0.796 | Antiinflammatory | 0.796 0.016 CID_131770037 | CID_131770037 | |
| 0.714 | 0.005 | 0.714 | Cardiotonic | 0.663 0.005 CID_131770037 | ||
| 0.709 | 0.001 | 0.709 | Progesterone antagonist | 0.234 0.004 CID_131770037 | ||
| 0.72 | 0.018 | 0.72 | Transcription factor NF kappa B inhibitor | 0.291 0.099 CID_131770037 | ||
| 0.646 | 0.008 | 0.646 | Nitric oxide antagonist | 0.428 0.022 CID_131770037 | ||
| 0.648 | 0.013 | 0.648 | Cholesterol antagonist | 0.197 0.167 CID_131770037 | ||
| 0.624 | 0.014 | 0.624 | Antithrombotic | 0.537 0.024 CID_131770037 | ||
| 0.598 | 0.002 | 0.598 | Lipocortins synthesis antagonist | 0.515 0.004 CID_131770037 | ||
| 0.566 | 0.001 | 0.566 | Progesterone agonist | 0.387 0.001 CID_131770037 | ||
| 0.519 | 0.003 | 0.519 | Sodium/bile acid cotransporter inhibitor | 0.483 0.004 CID_131770037 | ||
| 0.499 | 0.003 | 0.499 | Aromatase inhibitor | 0.148 0.013 CID_131770037 | ||
| 0.518 | 0.028 | 0.518 | Immunosuppressant | 0.331 0.097 CID_131770037 | ||
| 0.477 | 0.023 | 0.477 | Apoptosis antagonist | 0.273 0.105 CID_131770037 | ||
| 0.454 | 0.003 | 0.454 | Cholesterol synthesis inhibitor | 0.217 0.023 CID_131770037 | ||
| 0.462 | 0.016 | 0.462 | Hypolipemic | 0.444 0.018 CID_131770037 | ||
| 0.491 | 0.063 | 0.491 | Caspase 9 stimulant | |||
| 0.438 | 0.012 | 0.438 | Anesthetic general | |||
| 0.428 | 0.006 | 0.428 | Interleukin 6 antagonist | 0.248 0.023 CID_131770037 | ||
| 0.454 | 0.055 | 0.466 | Antibacterial | 0.466 0.051 CID_131770037 | CID_131770037 | |
| 0.423 | 0.025 | 0.423 | Hypoxia-inducible factor 1 alpha inhibitor | 0.207 0.144 CID_131770037 | ||
| 0.46 | 0.063 | 0.477 | Cyclophilin D inhibitor | 0.477 0.057 CID_131770037 | CID_131770037 | |
| 0.395 | 0.006 | 0.395 | Neurotrophic factor enhancer | |||
| 0.391 | 0.011 | 0.391 | Interferon gamma antagonist | |||
| 0.326 | 0.003 | 0.326 | Estradiol 17 beta-dehydrogenase inhibitor | 0.105 0.01 CID_131770037 | ||
| 0.324 | 0.002 | 0.324 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.043 0.014 CID_131770037 | ||
| 0.359 | 0.042 | 0.359 | Interleukin 2 agonist | |||
| 0.317 | 0.003 | 0.317 | 5-Alpha-reductase inhibitor | 0.189 0.005 CID_131770037 | ||
| 0.315 | 0.015 | 0.315 | Protein kinase stimulant | |||
| 0.295 | 0.002 | 0.295 | Arachidonic acid antagonist | 0.284 0.003 CID_131770037 | ||
| 0.355 | 0.063 | 0.355 | Immunostimulant | |||
| 0.289 | 0.023 | 0.289 | Melanin inhibitor | |||
| 0.265 | 0.005 | 0.265 | Microtubule formation inhibitor | 0.169 0.029 CID_131770037 | ||
| 0.26 | 0.002 | 0.26 | RNA-directed RNA polymerase stimulant | 0.134 0.004 CID_131770037 | ||
| 0.287 | 0.033 | 0.287 | Hepatoprotectant | 0.171 0.088 CID_131770037 | ||
| 0.248 | 0.002 | 0.248 | 5-Alpha-reductase 2 inhibitor | |||
| 0.26 | 0.015 | 0.26 | DNA polymerase I inhibitor | 0.157 0.046 CID_131770037 | ||
| 0.277 | 0.034 | 0.277 | P-glycoprotein inhibitor | |||
| 0.261 | 0.023 | 0.261 | Phospholipase C inhibitor | 0.141 0.127 CID_131770037 | ||
| 0.243 | 0.013 | 0.243 | Farnesoid X receptor antagonist | 0.119 0.105 CID_131770037 | ||
| 0.284 | 0.064 | 0.284 | DNA damaging | |||
| 0.216 | 0.002 | 0.216 | Na+ K+ transporting ATPase inhibitor | 0.147 0.006 CID_131770037 | ||
| 0.222 | 0.007 | 0.222 | Estrogen agonist | 0.151 0.011 CID_131770037 | ||
| 0.217 | 0.003 | 0.217 | Anabolic | 0.142 0.023 CID_131770037 | ||
| 0.213 | 0.01 | 0.213 | Antineoplastic alkaloid | |||
| 0.206 | 0.003 | 0.206 | 5-Alpha-reductase 1 inhibitor | 0.03 0.009 CID_131770037 | ||
| 0.197 | 0.004 | 0.197 | Glycine receptor antagonist | 0.078 0.061 CID_131770037 | ||
| 0.281 | 0.089 | 0.281 | Caspase 3 stimulant | |||
| 0.201 | 0.013 | 0.201 | Estrogen antagonist | 0.133 0.035 CID_131770037 | ||
| 0.198 | 0.012 | 0.198 | Hedgehog signaling inhibitor | |||
| 0.252 | 0.069 | 0.252 | Angiogenesis stimulant | |||
| 0.259 | 0.079 | 0.259 | Antioxidant | |||
| 0.241 | 0.072 | 0.241 | DNA synthesis inhibitor | |||
| 0.171 | 0.004 | 0.171 | Glucocorticoid antagonist | 0.093 0.005 CID_131770037 | ||
| 0.244 | 0.083 | 0.244 | Interleukin agonist | |||
| 0.162 | 0.005 | 0.162 | Glycine receptor agonist | |||
| 0.179 | 0.025 | 0.179 | Antineoplastic antibiotic | |||
| 0.174 | 0.031 | 0.174 | Adenylate cyclase stimulant | |||
| 0.209 | 0.066 | 0.209 | Platelet adhesion inhibitor | |||
| 0.169 | 0.027 | 0.169 | Pregnane X receptor agonist | |||
| 0.148 | 0.007 | 0.148 | Estrogen receptor beta agonist | 0.11 0.01 CID_131770037 | ||
| 0.144 | 0.006 | 0.144 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.042 0.038 CID_131770037 | ||
| 0.12 | 0.003 | 0.13 | Lipocortins synthesis agonist | 0.13 0.002 CID_131770037 | CID_131770037 | |
| 0.127 | 0.014 | 0.127 | Bile acid receptor antagonist | |||
| 0.128 | 0.016 | 0.128 | Estrogen receptor alpha antagonist | |||
| 0.108 | 0.008 | 0.108 | Estrogen receptor alpha agonist | 0.071 0.013 CID_131770037 | ||
| 0.201 | 0.104 | 0.201 | Aldehyde oxidase inhibitor | |||
| 0.1 | 0.003 | 0.1 | Glucose-6-phosphate dehydrogenase inhibitor | 0.052 0.01 CID_131770037 | ||
| 0.105 | 0.009 | 0.144 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.144 0.005 CID_131770037 | CID_131770037 | |
| 0.118 | 0.024 | 0.118 | Opioid kappa receptor antagonist | |||
| 0.099 | 0.005 | 0.099 | Estrone sulfatase inhibitor | 0.079 0.005 CID_131770037 | ||
| 0.138 | 0.053 | 0.138 | Alkylator | |||
| 0.143 | 0.063 | 0.143 | Ca2+-transporting ATPase inhibitor | |||
| 0.084 | 0.005 | 0.084 | Farnesoid X receptor agonist | |||
| 0.116 | 0.037 | 0.116 | Estrogen receptor beta antagonist | 0.096 0.072 CID_131770037 | ||
| 0.19 | 0.112 | 0.19 | Peptidyltransferase inhibitor | |||
| 0.085 | 0.018 | 0.085 | Protein 50S ribosomal subunit inhibitor | |||
| 0.1 | 0.033 | 0.1 | Vanilloid agonist | |||
| 0.078 | 0.012 | 0.078 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.144 | 0.078 | 0.144 | NOS3 expression enhancer | |||
| 0.17 | 0.108 | 0.17 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.095 | 0.033 | 0.095 | Keratolytic | |||
| 0.069 | 0.007 | 0.069 | Microtubule stabilization | 0.052 0.025 CID_131770037 | ||
| 0.073 | 0.012 | 0.073 | Vanilloid 2 antagonist | 0.061 0.022 CID_131770037 | ||
| 0.062 | 0.005 | 0.062 | HMG CoA reductase inhibitor | 0.051 0.007 CID_131770037 | ||
| 0.196 | 0.14 | 0.196 | Transcription factor STAT3 inhibitor | |||
| 0.073 | 0.021 | 0.073 | Heme oxygenase stimulant | 0.06 0.046 CID_131770037 | ||
| 0.057 | 0.006 | 0.057 | Tubulin agonist | 0.035 0.021 CID_131770037 | ||
| 0.054 | 0.003 | 0.054 | Hedgehog signaling activator | |||
| 0.086 | 0.037 | 0.128 | CDC25A inhibitor | 0.128 0.017 CID_131770037 | CID_131770037 | |
| 0.054 | 0.005 | 0.054 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.093 | 0.047 | 0.093 | Transcription factor NF kappa B stimulant | |||
| 0.05 | 0.004 | 0.054 | Glucocorticoid agonist | 0.054 0.004 CID_131770037 | CID_131770037 | |
| 0.081 | 0.04 | 0.081 | Phosphofructokinase-1 inhibitor | 0.059 0.058 CID_131770037 | ||
| 0.055 | 0.015 | 0.055 | Parathyroid hormone antagonist | |||
| 0.094 | 0.059 | 0.094 | ABCA1 expression enhancer | |||
| 0.033 | 0.005 | 0.033 | Corticosteroid-like | 0.022 0.014 CID_131770037 | ||
| 0.113 | 0.086 | 0.113 | Amylase inhibitor | |||
| 0.038 | 0.012 | 0.038 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.029 | 0.004 | 0.029 | Vitamin D receptor agonist | |||
| 0.025 | 0.004 | 0.025 | Telomerase stimulant | |||
| 0.027 | 0.009 | 0.027 | Vitamin D receptor antagonist | |||
| 0.049 | 0.031 | 0.049 | Potassium channel Kv1.3 blocker | |||
| 0.08 | 0.066 | 0.08 | Estrogen-related receptor beta agonist | |||
| 0.092 | 0.078 | 0.092 | Expectorant | |||
| 0.044 | 0.029 | 0.044 | Opioid kappa receptor agonist | |||
| 0.028 | 0.015 | 0.028 | Toll-Like receptor 4 agonist | |||
| 0.016 | 0.004 | 0.016 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.013 0.007 CID_131770037 | ||
| 0.011 | 0.002 | 0.011 | Transcortin receptor antagonist | |||
| 0.051 | 0.042 | 0.051 | GABA receptor antagonist | |||
| 0.101 | 0.094 | 0.101 | Cholinergic antagonist | |||
| 0.1 | 0.093 | 0.1 | Acetylcholine antagonist | |||
| 0.138 | 0.133 | 0.138 | Non-steroidal antiinflammatory agent | |||
| 0.038 | 0.033 | 0.038 | Liver X receptor alpha agonist | |||
| 0.054 | 0.049 | 0.054 | Pregnane X receptor antagonist | |||
| 0.085 | 0.081 | 0.085 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.047 | 0.045 | 0.047 | GABA A receptor antagonist | |||
| 0.075 | 0.073 | 0.075 | Ornithine decarboxylase inhibitor | |||
| 0.015 | 0.014 | 0.015 | Ileal bile acid transport inhibitor | |||
| 0.174 | 0.188 | 0.2 | Gastrin inhibitor | 0.2 0.15 CID_131770037 | CID_131770037 | |
| 0.08 | 0.103 | 0.127 | Protein-tyrosine phosphatase 1B inhibitor | 0.127 0.058 CID_131770037 | CID_131770037 | |
| 0.008 | 0.103 | 0.023 | Purinergic P2X agonist | 0.023 0.022 CID_131770037 | CID_131770037 | |
| 0.089 | 0.213 | 0.134 | Hemostatic | 0.134 0.089 CID_131770037 | CID_131770037 | |
| 0.063 | 0.23 | 0.205 | Protein-tyrosine phosphatase inhibitor | 0.205 0.045 CID_131770037 | CID_131770037 | |
| 0.01 | 0.308 | 0.165 | HIV-1 integrase (Strand Transfer) inhibitor | 0.165 0.012 CID_131770037 | CID_131770037 | |
| 0.01 | 0.327 | 0.169 | HIV-1 integrase (3'-Processing) inhibitor | 0.169 0.012 CID_131770037 | CID_131770037 | |
| 0.027 | 0.352 | 0.15 | GABA C receptor antagonist | 0.15 0.03 CID_131770037 | CID_131770037 | |
| 0.018 | 0.624 | 0.093 | Thioredoxin inhibitor | 0.093 0.057 CID_131770037 | CID_131770037 | |
| 0.005 | 0.93 | 0.066 | Purinergic P2Y2 antagonist | 0.066 0.007 CID_131770037 | CID_131770037 | |
| 0.004 | 0.936 | 0.186 | Dual specificity phosphatase 3 inhibitor | 0.186 0.069 CID_131770037 | CID_131770037 | |
| 0.005 | 0.958 | 0.178 | Dual specificity phosphatase inhibitor | 0.178 0.069 CID_131770037 | CID_131770037 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |